Viewing Study NCT01582932


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-01-04 @ 5:34 PM
Study NCT ID: NCT01582932
Status: COMPLETED
Last Update Posted: 2019-01-22
First Post: 2012-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis
Sponsor: Mayne Pharma International Pty Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-04
Start Date Type: ACTUAL
Primary Completion Date: 2018-08
Primary Completion Date Type: ACTUAL
Completion Date: 2018-08
Completion Date Type: ACTUAL
First Submit Date: 2012-03-29
First Submit QC Date: None
Study First Post Date: 2012-04-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-01-17
Last Update Post Date: 2019-01-22
Last Update Post Date Type: ACTUAL